Caitlyn James.

Caitlin James

Graduate student
Roswell Park Comprehensive Cancer Center

Caitlin James is a Ph.D. candidate at Roswell Park Comprehensive Cancer Center in Buffalo, New York. After earning her B.S. in Biology at the University of Pittsburgh at Bradford, she began her thesis work at Roswell, which aims to identify molecular mechanisms by which chronic beta-adrenergic signaling impairs CD8 T-cell CD28 co-stimulatory signaling. She also studies how housing temperatures affect laboratory mouse T-cell biology.

James is a National Cancer Institute Ruth L. Kirschstein National Research Service Award F31 Fellow and T32 Trainee.

Explore more from The Transmitter

Autism scientists push back on CDC’s inaccurate vaccine claims

The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.

By The Transmitter
21 November 2025 | 6 min read

Gene replacement therapy normalizes some traits in SYNGAP1 model mice

The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.

By Charles Q. Choi
20 November 2025 | 5 min read

Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans

Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.

By Paul Middlebrooks
19 November 2025 | 1 min read

privacy consent banner

Privacy Preference

We use cookies to provide you with the best online experience. By clicking “Accept All,” you help us understand how our site is used and enhance its performance. You can change your choice at any time. To learn more, please visit our Privacy Policy.